![Ian McBeath](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian McBeath
Amministratore Delegato presso
Naegis Pharmaceuticals, Inc.
Profilo
Ian McBeath is the founder of Mesentech, Inc., Alpha-9 Oncology, Inc. Mr. McBeath is Chief Executive Officer at Naegis Pharmaceuticals, Inc. Mr. McBeath was President & Chief Executive Officer at EACOM Timber Corp., Chief Executive Officer at BioVex, Inc., Chief Executive Officer at Sarossa Capital Ltd., Chief Executive Officer at BioVex Ltd., Chief Executive Officer at Novation Pharmaceuticals, Inc., Principal at Johnson & Johnson, Principal at AstraZeneca PLC, and Vice President-Europe Region at Gensia Sicor Pharmaceuticals, Inc.
Posizioni attive di Ian McBeath
| Società | Posizione | Inizio |
|---|---|---|
Naegis Pharmaceuticals, Inc.
 Naegis Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for retinal and inflammatory eye diseases | Amministratore Delegato | - |
Precedenti posizioni note di Ian McBeath
| Società | Posizione | Fine |
|---|---|---|
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Fondatore | - |
Gensia Sicor Pharmaceuticals, Inc. | Corporate Officer/Principal | - |
Mesentech, Inc.
 Mesentech, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drug conjugates | Fondatore | - |
| JOHNSON & JOHNSON | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
2
Relazioni di 1° grado
11
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 11 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
EACOM Timber Corp.
 EACOM Timber Corp. Forest ProductsNon-Energy Minerals Engages in manufacturing, marketing and distribution of lumber and wood-based value-added products | Non-Energy Minerals |
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Sarossa Capital Ltd.
 Sarossa Capital Ltd. Financial ConglomeratesFinance Provides investment services | Finance |
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Gensia Sicor Pharmaceuticals, Inc. | |
Novation Pharmaceuticals, Inc.
 Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Operates as a biotechnology research and development company | Health Services |
Naegis Pharmaceuticals, Inc.
Naegis Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapies for retinal and inflammatory eye diseases | Commercial Services |
Mesentech, Inc.
Mesentech, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drug conjugates | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
